Close

Pfizer introduces new line of dietary supplements

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Pfizer Consumer Healthcare has introduced a new line of dietary supplements ProNutrients, which are formulated to naturally work with a multivitamin.The dietary supplements include Omega-3, Probiotic, and Fruit & Veggie.

Omega-3 provides two Omega-3s (according to Eicosapentaenoic Acid/EPA and Docosahexaenoic Acid/DHA standards) in an ultra-concentrated MiniGel.Omega-3, due to its smaller size, is easy to swallow and support heart health, brain structure and eye structure, claims the company.

New ProNutrients Fruit & Veggie is obtained from grapes, blueberries, raspberries, plums, carrots and tomatoes which support cell protection and general health.

Moreover, the new Probiotic is a blend of powders wrapped in packets and are designed to ensure the bacteria arrive active and ready to work in the digestive tract and support immune health and digestive balance.The company has also introduced Centrum Specialist with specific benefits includes Prenatal, Vision, Energy and Heart.

 

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back